West Pharma (WST) Tops Q2 EPS by 34c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
BofA Securities Upgrades West Pharmaceutical (WST) to Buy
July 21, 2020 9:17 AM EDTBofA Securities upgraded West Pharmaceutical (NYSE: WST) from Neutral to Buy.
For an analyst ratings summary and ratings history on West Pharmaceutical click here. For more ratings news on West Pharmaceutical click here.
Shares of West Pharmaceutical closed at $255.23 yesterday.
... MoreBofA Securities Upgrades West Pharmaceutical (WST) to Buy
July 21, 2020 7:08 AM EDTBofA Securities upgraded West Pharmaceutical (NYSE: WST) from Neutral to Buy.
For an analyst ratings summary and ratings history on West Pharmaceutical click here. For more ratings news on West Pharmaceutical click here.
Shares of West Pharmaceutical closed at $251.84 yesterday.
... More